22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis
- 1 December 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (6) , 2040-2047
- https://doi.org/10.1046/j.1523-1755.1999.00772.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Renal osteodystrophy in rats with reduced renal massNephrology Dialysis Transplantation, 1996
- Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary studyNephrology Dialysis Transplantation, 1996
- Renal bone disease 1990: An unmet challenge for the nephrologistKidney International, 1990
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Renal osteodystrophyKidney International, 1980
- Stain Technology a Bone Stain for Osteoid Seams in Fresh, Unembedded, Mineralized BoneStain Technology, 1974